Pattern Bioscience specializes in the rapid identification of bacterial infections and their antibiotic resistance profiles. The company uses advanced digital technology that combines single-cell analysis with artificial intelligence to provide results for identification and antibiotic susceptibility testing in just four hours, a significant reduction from traditional methods that can take days. Its primary customers are hospitals and healthcare providers, including lab directors and infection prevention specialists. Unlike competitors, Pattern Bioscience focuses on delivering faster and more accurate diagnostics, which helps reduce unnecessary antibiotic prescriptions and addresses the critical issue of antibiotic resistance. The company's goal is to improve patient outcomes and combat antibiotic misuse in healthcare settings.